PROactive study shows reduced heart attacks and strokes in type 2 diabetics on pioglitazone HCI (Actos) therapy.
D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy*; D004311:Double-Blind Method; D006801:Humans; D009203:Myocardial Infarction / Q000517:prevention & control*; D000077205:Pioglitazone; D011446:Prospective Studies; D020521:Stroke / Q000517:prevention & control*; D045162:Thiazolidinediones / Q000627:therapeutic use*
D045162:Thiazolidinediones; D000077205:Pioglitazone